These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19748813)

  • 41. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of leucocyte reduction on the potential alloimmunogenicity of leucocytes in fresh-frozen plasma products.
    Hiruma K; Okuyama Y
    Vox Sang; 2001 Jan; 80(1):51-6. PubMed ID: 11339069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developments in component therapy: novel components and new uses for familiar preparations.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2002; 15(2):116-24; quiz 125-7. PubMed ID: 12776775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guidelines for the use of fresh frozen plasma.
    De Backer D; Vandekerckhove B; Stanworth S; Williamson L; Hermans C; Van der Linden P; Hübner R; Baele P; Jochmans K; Ferrant A; Lambermont M; Muylle L; Toungouz M
    Acta Clin Belg; 2008; 63(6):381-90. PubMed ID: 19170354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy.
    Novak DJ; Tyler LN; Reddy RL; Barsoom MJ
    J Clin Apher; 2008; 23(6):183-5. PubMed ID: 19003884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elective fresh frozen plasma in the critically ill: what is the evidence?
    Verghese SG
    Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M; Dziegiel M; Hegaard HK; Bidstrup M; Jonsbo F; Christensen B; Hedegaard M
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble Human Leukocyte Antigen class I antigen and interleukin-12 in hepatectomized patients.
    Shimura T; Morinaga N; Suzuki H; Araki K; Kobayashi T; Ishizaki M; Kuwano H
    ANZ J Surg; 2009 Jun; 79(6):462-6. PubMed ID: 19566870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evolution of indications and consumptions of fresh frozen plasma from 1997 to 2003 in a teaching Hospital].
    Boulat C; Clero B
    Transfus Clin Biol; 2005 Jul; 12(3):251-6. PubMed ID: 15953748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Severe bleeding in a patient with anti-c alloantibodies and a rare Rhesus phenotype treated with compatible erythrocyte concentrate from the blood bank of the Council of Europe].
    Sonke GS; Overbeeke MA; de Graaff WE; Elisen MG
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2628-32. PubMed ID: 16355576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypersensitivity transfusion reactions to fresh frozen plasma: a retrospective analysis of the French hemovigilance network.
    Tacquard C; Andreu G; Meyer N; Carlier M; Py JY; Drouet C; Bienvenu J; Mertes PM; Boudjedir K
    Transfus Med Rev; 2022 Apr; 36(2):77-81. PubMed ID: 35501216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of plasma: clinical indications and types of plasma components in Sweden.
    Norda R; Tynell E
    Transfus Clin Biol; 2007 Dec; 14(6):560-3. PubMed ID: 18407774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction in plasma transfusion after enforcement of transfusion guidelines.
    Tavares M; DiQuattro P; Nolette N; Conti G; Sweeney J
    Transfusion; 2011 Apr; 51(4):754-61. PubMed ID: 20946197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transfusion packages for massively bleeding patients: the effect on clot formation and stability as evaluated by Thrombelastograph (TEG).
    Johansson PI; Bochsen L; Stensballe J; Secher NH
    Transfus Apher Sci; 2008 Aug; 39(1):3-8. PubMed ID: 18583193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testing of blood products in a polytrauma model: results of a multi-institutional randomized preclinical trial.
    Alam HB; Bice LM; Butt MU; Cho SD; Dubick MA; Duggan M; Englehart MS; Holcomb JB; Morris MS; Prince MD; Schreiber MA; Shults C; Sondeen JL; Tabbara M; Tieu BH; Underwood SA;
    J Trauma; 2009 Oct; 67(4):856-64. PubMed ID: 19820596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.
    Saadah NH; Schipperus MR; Wiersum-Osselton JC; van Kraaij MG; Caram-Deelder C; Beckers EAM; Leyte A; Rondeel JMM; de Vooght KMK; Weerkamp F; Zwaginga JJ; van der Bom JG
    Haematologica; 2020 Apr; 105(4):1158-1165. PubMed ID: 31273090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse effects of plasma transfusion.
    Pandey S; Vyas GN
    Transfusion; 2012 May; 52 Suppl 1(Suppl 1):65S-79S. PubMed ID: 22578374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.